Literature DB >> 31377243

Heterologous protection against Crimean-Congo hemorrhagic fever in mice after a single dose of replicon particle vaccine.

Jessica R Spengler1, Stephen R Welch2, Florine E M Scholte2, JoAnn D Coleman-McCray2, Jessica R Harmon2, Stuart T Nichol2, Éric Bergeron2, Christina F Spiropoulou2.   

Abstract

No vaccines are currently licensed to prevent Crimean-Congo hemorrhagic fever virus (CCHFV) infection, which can cause mild self-limiting clinical signs or severe, often fatal hemorrhagic fever disease. Here we continued investigations into the utility of a single-dose virus replicon particle (VRP) vaccine regimen by assessing protection against Turkey or Oman strains of CCHFV. We found that all mice were completely protected from disease, supporting broad applicability of this platform for CCHFV prevention. Published by Elsevier B.V.

Entities:  

Keywords:  Crimean-Congo hemorrhagic fever; Disease; Hemorrhagic fever; Heterologous protection; IFNAR(−/)(−) mice; Replicon particle; VRP; Vaccine; Virus

Mesh：

Substances：

Year:  2019        PMID： 31377243      PMCID： PMC6773275          DOI： 10.1016/j.antiviral.2019.104573

Source DB:  PubMed          Journal:  Antiviral Res        ISSN： 0166-3542            Impact factor:   5.970


  19 in total

1.  Antibody response in Crimean-Congo hemorrhagic fever.

Authors:  A J Shepherd; R Swanepoel; P A Leman
Journal:  Rev Infect Dis       Date:  1989 May-Jun

2.  Crimean-Congo Hemorrhagic Fever Virus Subunit Vaccines Induce High Levels of Neutralizing Antibodies But No Protection in STAT1 Knockout Mice.

Authors:  Jeroen Kortekaas; Rianka P M Vloet; Alexander J McAuley; Xiaoli Shen; Berend Jan Bosch; Laura de Vries; Rob J M Moormann; Dennis A Bente
Journal:  Vector Borne Zoonotic Dis       Date:  2015-12       Impact factor: 2.133

3.  Crimean-Congo hemorrhagic fever virus infection is lethal for adult type I interferon receptor-knockout mice.

Authors:  Sándor Bereczky; Gunnel Lindegren; Helen Karlberg; Sara Akerström; Jonas Klingström; Ali Mirazimi
Journal:  J Gen Virol       Date:  2010-02-17       Impact factor: 3.891

4.  A cynomolgus macaque model for Crimean-Congo haemorrhagic fever.

Authors:  Elaine Haddock; Friederike Feldmann; David W Hawman; Marko Zivcec; Patrick W Hanley; Greg Saturday; Dana P Scott; Tina Thomas; Miša Korva; Tatjana Avšič-Županc; David Safronetz; Heinz Feldmann
Journal:  Nat Microbiol       Date:  2018-04-09       Impact factor: 17.745

5.  Protective effects of a Modified Vaccinia Ankara-based vaccine candidate against Crimean-Congo Haemorrhagic Fever virus require both cellular and humoral responses.

Authors:  Stuart D Dowall; Victoria A Graham; Emma Rayner; Laura Hunter; Robert Watson; Irene Taylor; Antony Rule; Miles W Carroll; Roger Hewson
Journal:  PLoS One       Date:  2016-06-07       Impact factor: 3.240

6.  Assessment of Inhibitors of Pathogenic Crimean-Congo Hemorrhagic Fever Virus Strains Using Virus-Like Particles.

Authors:  Marko Zivcec; Maureen G Metcalfe; César G Albariño; Lisa W Guerrero; Scott D Pegan; Christina F Spiropoulou; Éric Bergeron
Journal:  PLoS Negl Trop Dis       Date:  2015-12-01

7.  Vesicular Stomatitis Virus-Based Vaccine Protects Mice against Crimean-Congo Hemorrhagic Fever.

Authors:  Sergio E Rodriguez; Robert W Cross; Karla A Fenton; Dennis A Bente; Chad E Mire; Thomas W Geisbert
Journal:  Sci Rep       Date:  2019-05-23       Impact factor: 4.379

8.  Bovine Herpesvirus Type 4 (BoHV-4) Vector Delivering Nucleocapsid Protein of Crimean-Congo Hemorrhagic Fever Virus Induces Comparable Protective Immunity against Lethal Challenge in IFNα/β/γR-/- Mice Models.

Authors:  Touraj Aligholipour Farzani; Katalin Földes; Alireza Hanifehnezhad; Burcu Yener Ilce; Seval Bilge Dagalp; Neda Amirzadeh Khiabani; Koray Ergünay; Feray Alkan; Taner Karaoglu; Hurrem Bodur; Aykut Ozkul
Journal:  Viruses       Date:  2019-03-09       Impact factor: 5.048

9.  A novel vaccine against Crimean-Congo Haemorrhagic Fever protects 100% of animals against lethal challenge in a mouse model.

Authors:  Karen R Buttigieg; Stuart D Dowall; Stephen Findlay-Wilson; Aleksandra Miloszewska; Emma Rayner; Roger Hewson; Miles W Carroll
Journal:  PLoS One       Date:  2014-03-12       Impact factor: 3.240

10.  A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease.

Authors:  S D Dowall; K R Buttigieg; S J D Findlay-Wilson; E Rayner; G Pearson; A Miloszewska; V A Graham; M W Carroll; R Hewson
Journal:  Hum Vaccin Immunother       Date:  2016       Impact factor: 3.452
View more
  6 in total

Review 1.  The use of mice lacking type I or both type I and type II interferon responses in research on hemorrhagic fever viruses. Part 2: Vaccine efficacy studies.

Authors:  Marko Zivcec; Christina F Spiropoulou; Jessica R Spengler
Journal:  Antiviral Res       Date:  2020-01-22       Impact factor: 5.970

Review 2.  Immunobiology of Crimean-Congo hemorrhagic fever.

Authors:  Sergio E Rodriguez; David W Hawman; Teresa E Sorvillo; T Justin O'Neal; Brian H Bird; Luis L Rodriguez; Éric Bergeron; Stuart T Nichol; Joel M Montgomery; Christina F Spiropoulou; Jessica R Spengler
Journal:  Antiviral Res       Date:  2022-01-11       Impact factor: 10.103

3.  Immune responses in multiple hosts to Nucleocapsid Protein (NP) of Crimean-Congo Hemorrhagic Fever Virus (CCHFV).

Authors:  Elif Karaaslan; Nesibe Selma Çetin; Merve Kalkan-Yazıcı; Sevde Hasanoğlu; Faruk Karakeçili; Aykut Özdarendeli; Ahmet Kalkan; Ali Osman Kılıç; Mehmet Ziya Doymaz
Journal:  PLoS Negl Trop Dis       Date:  2021-12-01

4.  Viral replicon particles protect IFNAR-/- mice against lethal Crimean-Congo hemorrhagic fever virus challenge three days after vaccination.

Authors:  Jessica R Spengler; Stephen R Welch; Florine E M Scholte; Sergio E Rodriguez; Jessica R Harmon; JoAnn D Coleman-McCray; Stuart T Nichol; Joel M Montgomery; Éric Bergeron; Christina F Spiropoulou
Journal:  Antiviral Res       Date:  2021-05-24       Impact factor: 10.103

Review 5.  Crimean-Congo Hemorrhagic Fever Virus: Advances in Vaccine Development.

Authors:  Thomas Tipih; Felicity Jane Burt
Journal:  Biores Open Access       Date:  2020-05-12

6.  Fluorescent Crimean-Congo hemorrhagic fever virus illuminates tissue tropism patterns and identifies early mononuclear phagocytic cell targets in Ifnar-/- mice.

Authors:  Stephen R Welch; Jana M Ritter; Anita K McElroy; Jessica R Harmon; JoAnn D Coleman-McCray; Florine E M Scholte; Gary P Kobinger; Éric Bergeron; Sherif R Zaki; Stuart T Nichol; Jessica R Spengler; Christina F Spiropoulou
Journal:  PLoS Pathog       Date:  2019-12-02       Impact factor: 6.823
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.